INCREASED CONTRACTILE RESPONSE TO PHENYLEPHRINE IN DETRUSOR OF PATIENTS WITH BLADDER OUTLET OBSTRUCTION: EFFECT OF THE α1A AND α1D-ADRENERGIC RECEPTOR ANTAGONIST TAMSULOSIN
- 1 February 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 173 (2) , 657-661
- https://doi.org/10.1097/01.ju.0000143198.16610.84
Abstract
Purpose: α1-Adrenergic receptor (α1-AR) antagonists are effective for treating patients with lower urinary tract symptoms associated with bladder outlet obstruction (BOO). In humans up-regulation of α1-AR function in the detrusor in patients with BOO has been suggested but to our knowledge it is not yet confirmed. We investigated the effect of phenylephrine, an α1-AR agonist, on isometric tension in small detrusor muscle biopsies from patients with lower urinary tract symptoms and BOO compared with controls. Materials and Methods: Detrusor biopsies were obtained from 7 men with BOO undergoing prostatectomy and 7 undergoing cystectomy for bladder cancer (controls). Patients were characterized by symptom score and urodynamics. Isometric tension was measured in detrusor biopsies with an especially built mini myograph. Results: Mean International Prostate Symptom Score ± SEM in patients with BOO and controls were 22.3 ± 2.3 and 4.0 ± 0.8, respectively. Phenylephrine (10−6 to 10−3 M) induced a significant contractile response increase in detrusor biopsies from patients with BOO compared with controls at all concentrations. Tamsulosin (0.1 to 3.0 nM) inhibited phenylephrine induced contraction in a dose dependent manner. Conclusions: To our knowledge this functional study shows for the first time a highly significant increase in contractile force to phenylephrine in patients with BOO compared with controls. These results suggest up-regulation of α1-AR function in BOO since contractile responses were potently inhibited by the α1A/D-AR antagonist tamsulosin.Keywords
This publication has 16 references indexed in Scilit:
- Storage and voiding symptoms: pathophysiologic aspectsUrology, 2003
- A Quantitative Analysis of mRNA Expression of α1 and β-adrenoceptor Subtypes and Their Functional Roles in Human Normal and Obstructed BladdersJournal of Urology, 2003
- α-Adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with α-adrenoceptor antagonistsWorld Journal of Urology, 2002
- MODULATION OF BLADDER α1-ADRENERGIC RECEPTOR SUBTYPE EXPRESSION BY BLADDER OUTLET OBSTRUCTIONJournal of Urology, 2002
- α1-Adrenergic receptor regulation: basic science and clinical implicationsPharmacology & Therapeutics, 2000
- Novel role for α1‐adrenergic receptor subtypes in lower urinary tract symptomsBJU International, 2000
- LOCALIZATION AND EXPRESSION OF THE alpha 1A-1 , alpha 1B AND alpha 1D-ADRENOCEPTORS IN HYPERPLASTIC AND NON-HYPERPLASTIC HUMAN PROSTATEJournal of Urology, 1999
- Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in womenNeurourology and Urodynamics, 1998
- alpha 1-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN DETRUSORJournal of Urology, 1998
- The effects of tamsulosin, a high affinity antagonist at functional α1A‐ and α1D‐adrenoceptor subtypesBritish Journal of Pharmacology, 1997